Pfizer Inc. (PFE) Reportedly In Talks To Expand Plant In Lee County
Reports allege that Pfizer Inc. (NYSE:PFE) is holding talks with Lee County officials as it considers investing $100 million to expand a plant located......(read more)
Posts Tagged ‘Is PFE A Good Stock To Buy Right Now?’
FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE......(read more)
Results In For Pfizer Inc. (PFE) Rheumatoid Arthritis Study
Results for the Pfizer Inc. (NYSE:PFE) oral strategy which was designed to treat rheumatoid arthritis in patients showing symptoms that range between......(read more)
Pfizer Inc. (PFE) Invest For Attractive Valuation And The 4% Dividend Yield
Investment Thesis Pfizer Inc. (NYSE:PFE) is one of the world’s largest pharmaceutical firms with sales exceeding $50 billion. The company is currently......(read more)
Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories. This......(read more)
Three Stocks To Buy For Valentines Day
It’s Valentine’s Day, and love is in the air. I joined CNBC’s Pauline Chiou to chat about stocks to commemorate the occasion. I’ll start with......(read more)
Pfizer Inc. (PFE) And Citibank To Work Together On $5 Billion Share Repurchase Program
Pfizer Inc. (NYSE:PFE) and Citibank have agreed to work together in the acceleration of share repurchase, which will involve buying back of Pfizer’s......(read more)
Pfizer Inc. (PFE)’s Breast Cancer Drug Too Expensive: Says NICE
The National Institute for Health and Care Excellence (NICE) has declared the latest breast cancer drug too expensive to justify its use. The country’......(read more)
Double Down On Dividends With These 2 Covered Calls
One of the most consistent, easiest to understand and easiest to implement option strategies is covered calls. Investor sell or write a call options over......(read more)
Pfizer Inc. (PFE) Challenges Businessmen To Come Up With Breast Cancer Solutions
Pfizer Inc. (NYSE:PFE) is stepping up its battle against breast cancer. Perhaps in an effort to help Ibrance sales, a top breast cancer treatment, the......(read more)
Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences......(read more)
FDA Agrees To Review IBRANCE (palbociclib) From Pfizer Inc. (PFE)
The U.S. Food and Drug Administration (FDA) has agreed to review a supplemental New Drug Application (sNDA) of CDK 4/6 inhibitor, IBRANCE (palbociclib......(read more)
Bristol-Myers Squibb Co (BMY) And Pfizer Inc. (PFE) Agree To $50 Million Loan To Portola Pharmaceuticals Inc (PTLA)
There is a need for additional funding towards the development and clinical studies of AndexXa, a new compound that is a prospective antidote for Factor......(read more)
Pfizer Inc. (PFE), Eli Lilly And Co (LLY) Impotence Drugs Price Increases Leave Patients Disgruntled
Pfizer Inc. (NYSE:PFE) and Eli Lilly and Co (NYSE:LLY) are yet again the subject of immense criticism as their practice of increasing the prices of key......(read more)
Pfizer Inc. (PFE) Files Lawsuit Against Texas HHSC
Pfizer Inc. (NYSE:PFE) recently filed a lawsuit against the Texas Health and Human Services Commission (HHSC) on accusations that the latter had revealed......(read more)
Pfizer Inc. (PFE) Signs Agreement With NCI To Explore Immunotherapy
Pfizer Inc. (NYSE:PFE) has confirmed its collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), on immunotherapy......(read more)
Pfizer Inc. (PFE) Teams Up With NIH NCI CCR On Immunotherapy
Pfizer Inc. (NYSE:PFE) has recently entered into a Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health (NIH)......(read more)
Pfizer Inc. (PFE) To Close 2 Britain Facilities, To Present New Xeljanz Data
Pfizer Inc. (NYSE:PFE) has recently revealed that it is closing two manufacturing plants in Britain. The company has claimed that the move is part of......(read more)
Novartis AG (ADR) (NVS) And Pfizer Inc. (PFE) Are In A Race To Gain Favor In Breast Cancer
Novartis AG (ADR) (NYSE:NVS) CDK4/6 breast cancer drug remains on track with Pfizer Inc. (NYSE:PFE)‘s Ibrance. The pharma giant has already obtained......(read more)
Pfizer Inc. (PFE): Safe And Steady Dividends
Pfizer Inc. (NYSE:PFE) is a blue-chip dividend stock that has paid a consistent dividend for multiple decades. Furthermore, over the last 20 years the......(read more)
Inside the FDA: Why The Pfizer, Inc. (PFE) Boxed Warning On Chantix Is Unlikely To Be Removed
On September 14, the Food and Drug Administration released two briefing documents for the joint meeting of two committees. These are the Psychopharmacologic......(read more)
Pfizer Inc. (PFE) Troxyca ER Receives FDA Panel Approval
Pfizer Inc. (NYSE:PFE) painkiller drug Troxyca ER has received the backing of an FDA advisory panel for marketing approval. Looking at the voting pattern......(read more)
Pfizer And Merck Earnings Previews: Mega-Cap Pharmas Try To Stem Revenue Erosion
This article is temporarily removed from Insider Monkey....(read more)
